Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients

N. Mozzanica, A. Cattaneo, D. Trabattoni, A. F. Finzi, E. Schmitt, E. Ferrario, M. Clerici, G. Vignati, M. L. Villa

Research output: Contribution to journalArticlepeer-review


We investigated the function of peripheral blood mononuclear cells (PBMC) in 16 patients with active psoriasis, in 15 patients with static psoriasis and in 27 healthy volunteers, by examining in vitro proliferation and antigen- and mitogen-stimulated production of interleukin-2 (IL-2) and IL-4. Plasma levels of the neuropeptide substance P were also determined. Defective alloantigen (ALLO)- and phytohaemagglutinin (PHA)-stimulated IL-2 production was detected in 42% and in 45% of psoriatic patients, respectively. The number of defective IL-2 responders was higher in static (60%) than in active (25%) psoriasis. The reduction of IL-2 responses in the former group was associated with an increase of IL-4 production. Thus PBMC of 66% of patients with static psoriasis but none of the patients with active psoriasis produced elevated amounts of PHA-stimulated IL-4. Variations of plasma substance P levels followed the same pattern of IL-4, being higher in static than in active psoriasis. These observations suggest a co-ordinated action of IL-4 and substance P as modulators of the clinical course of psoriasis. Our data show a possible correlation between the clinical evolution of psoriasis and the production of type-1 and type-2 cytokines, suggesting that the former may have a prominent role in the activation of psoriasis, while the latter may play a protective role.

Original languageEnglish
Pages (from-to)422-426
Number of pages5
Issue number3
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients'. Together they form a unique fingerprint.

Cite this